Holtz Children's Hospital, Jackson Memorial Hospital/University of Miami Medical Center
Miami, Florida, 33136, United States
NCT Number: NCT01620203
Intracranial Hemorrhage (ICH) is an important morbidity affecting premature infants and can have considerable effects on neurodevelopmental outcome.
The investigators showed that preterm infants with severe ICH have decreased cerebral oxygenation several weeks after the hemorrhage. The mechanisms involved in this state of decreased cerebral oxygenation in preterm infants and the effects on cerebral function are unknown.
This longitudinal observation study will evaluate physiologic parameters to determine trends in cerebral oxygenation and function in preterm infants with ICH in comparison to infants without ICH.
Looking for future studies?
Notify Me1 day–28 day
All sexes
Observational
Miami, Florida, 33136, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: postnatal weeks 4 and 8
Comparison of the progression of cerebral oxygenation measured non-invasively by near infrared spectroscopy over time in infants with ICH and non-ICH infants.
Time frame: post natal weeks 4 and 8
Comparisons of ultrasound measurements of superior vena cava flow and brain electrical activity by electroencephalography over time in infants with ICH and non-ICH infants.
Nelson Claure
Other
Observational Study in Preterm Infants With and Without Intracranial Hemorrhage: Longitudinal Assessment of Cerebral Oxygenation, Perfusion and Function
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00413946
Brain Damage, Chronic, Brain Diseases
Aarau, Switzerland
View Trial DetailsNCT06096051
Brain Diseases, Cardiovascular Diseases
Dallas, Texas, United States
View Trial DetailsNCT02661672
Brain Diseases, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT04062097
Brain Diseases, Brain Ischemia
Bad Aibling, Germany
View Trial Details